Trelagliptin

Overview

Trelagliptin (SYR-472) is a potent, orally active and highly selective DPP-4 inhibitor with an IC 50 of 4 nM. Trelagliptin succinate improves glycemic control in vivo and can be used for the study of type 2 diabetes mellitus (T2DM).

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > SARS-CoV-2 Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Dipeptidyl Peptidase

Product Information

• Catalog No.: HY-15408
• CAS No.: 865759-25-7
• Molecular Formula: C18H20FN5O2
• Molecular Weight: 357.38
• Purity: 99.81%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (7.00 mM); Clear solution
• Availability: In-stock

Source

Original product source